PROLOCK

Serial Number 88910494
606

Registration Progress

Application Filed
May 11, 2020
Under Examination
Jun 1, 2021
Approved for Publication
Apr 6, 2021
Published for Opposition
Apr 6, 2021
Registered

Trademark Image

PROLOCK

Basic Information

Serial Number
88910494
Filing Date
May 11, 2020
Published for Opposition
April 6, 2021
Abandonment Date
January 1, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 1, 2024
Classes
001

Rights Holder

PARABILIS MEDICINES, INC.

03
Address
30 ACORN PARK DRIVE
CAMBRIDGE, MA 02140

Ownership History

Fog Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Fog Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

PARABILIS MEDICINES, INC.

New Owner After Publication #1
03
CAMBRIDGE, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Nov 6, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jan 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 1, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 12, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 7, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 5, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 5, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 5, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 25, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 15, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 15, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 1, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 6, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 6, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 27, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 4, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 3, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 3, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 12, 2020 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Aug 12, 2020 GPRA F PRIORITY ACTION E-MAILED Loading...
Aug 12, 2020 CPRA R PRIORITY ACTION WRITTEN Loading...
Aug 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 14, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biomedical compounds, namely, amino acids for laboratory or research use; biomedical compounds, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for use in scientific and laboratory research; biomedical compounds, namely, miniproteins, and cell-penetrating miniproteins (CPMPs) in raw material form for use in scientific and laboratory research

Additional Information

Pseudo Mark
PRO LOCK

Classification

International Classes
001